Leerink Partners analyst Michael Cherny has maintained their bullish stance on CAH stock, giving a Buy rating on January 15.Stay Ahead of the ...

Law enforcement increasingly sees cannabis not as a criminal matter, but a regulatory one, except that no one is regulating ...

(CAH) on Thursday reported fiscal second-quarter earnings of $400 million. The Dublin, Ohio-based company said it had net income of $1.65 per share. Earnings, adjusted for one-time gains and costs, ...

Cardinal Health (NYSE:CAH – Free Report) had its price objective hoisted by JPMorgan Chase & Co. from $132.00 to $142.00 in a ...

Cardinal Health Inc. closed 2.50% below its 52-week high of $131.00, which the company reached on January 27th.

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

View Cardinal Health, Inc. (CAH) current and estimated P/E ratio data provided by Seeking Alpha.

In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE ... lot to be able to make it so smaller drug stores get product.” ...

Headquartered in Dublin, OH, Cardinal Health Inc. is a nation-wide drug ... Pharmaceutical and Specialty Solutions, Global Medical Products and Distribution and Others. CAH sits at a Zacks Rank ...